Farsam V[Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2011	1
2013	1
2014	1
2016	1
2017	1
2021	0

Page 1

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.

Farsam V, Basu A, Gatzka M, Treiber N, Schneider LA, Mulaw MA, Lucas T, Kochanek S, Dummer R, Levesque MP, Wlaschek M, Scharffetter-Kochanek K. Farsam V, et al. Oncotarget. 2016 Dec 13;7(50):83554-83569. doi: 10.18632/oncotarget.13446. Oncotarget. 2016. PMID: 27907906 Free PMC article.

MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.

Wilms C, Kroeger CM, Hainzl AV, Banik I, Bruno C, Krikki I, Farsam V, Wlaschek M, Gatzka MV. Wilms C, et al. Among authors: farsam v. Oncotarget. 2017 Jun 27;8(40):67287-67299. doi: 10.18632/oncotarget.18617. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978033 Free PMC article.

Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line.

Noori S, Hassan ZM, Farsam V. Noori S, et al. Among authors: farsam v. Chin J Integr Med. 2014 Aug;20(8):618-23. doi: 10.1007/s11655-013-1454-2. Epub 2013 Jun 15. Chin J Integr Med. 2014. PMID: 23771805

Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.

Farsam V, Hassan ZM, Zavaran-Hosseini A, Noori S, Mahdavi M, Ranjbar M. Farsam V, et al. Int Immunopharmacol. 2011 Nov;11(11):1802-8. doi: 10.1016/j.intimp.2011.07.008. Epub 2011 Aug 6. Int Immunopharmacol. 2011. PMID: 21824530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results